Elevated CRP Levels Linked to Higher Heart Failure Risk

A study found adults with higher inflammation markers face increased risks of heart failure and mortality.

Updated on Sept. 30, 2026 in Heart Disease

A close-up of a single glass laboratory test tube with clear liquid sitting on a white clinical surface.
Researchers have identified a significant association between elevated C-reactive protein levels and a higher risk of heart failure in adults, according to a new study. AI Illustration. Upload story photo >

Live Poll

Do you trust that routine blood tests accurately predict your long-term heart health?

Researchers have identified a significant association between elevated C-reactive protein (CRP) levels and a higher risk of heart failure and all-cause mortality in adults. This finding highlights the role of inflammation in long-term cardiovascular health for middle-aged and older populations.

Why it matters

Understanding the link between low-grade inflammation and heart health could refine risk assessment for cardiovascular disease. This evidence highlights why clinicians increasingly evaluate inflammatory markers alongside traditional risk factors to gauge potential heart failure progression.

In a study of 64,743 adults aged 40 to 80, researchers observed a 1.34 hazard ratio for incident heart failure and a 1.90 hazard ratio for all-cause mortality among those with elevated CRP levels (3.1 to 10.0 mg/L) compared to those with low levels (0.1 to 3.0 mg/L).

The players

International Journal of Cardiology

A peer-reviewed publication that disseminates research on the diagnosis and treatment of cardiovascular diseases.

The details

Researchers measured CRP, a protein produced by the liver in response to inflammation, using two consecutive blood tests to ensure consistent classification. The study found these elevated inflammation levels were linked to both heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Interestingly, this association appeared more pronounced in participants without obesity, suggesting the link between inflammation and cardiac function may operate independently of body mass index in certain groups.

Timeline

  1. September 30, 2026: The study was published in the International Journal of Cardiology.

Health Landscape

This research contributes to the long-standing inflammatory hypothesis of cardiovascular disease, which posits that chronic, low-grade inflammation is a primary driver of heart damage. It refines this model by characterizing the specific impact of CRP on heart failure outcomes across diverse adult cohorts.

If you have known cardiovascular risk factors, it is worth discussing with your doctor whether CRP monitoring could provide a more complete picture of your heart health. This finding is particularly relevant for individuals managing multiple risk factors who are concerned about long-term heart function.

The takeaway

Chronic inflammation can serve as a meaningful indicator for future heart health risks beyond traditional metrics. Consider asking your physician about your own inflammatory marker trends during your next routine cardiovascular checkup.

Further reading

For more on managing cardiovascular risk, visit our Heart Disease section.

Live Poll

Do you trust that routine blood tests accurately predict your long-term heart health?